Sussi Bagge Mortensen

Sussi Bagge Mortensen

Auto-generated profile, based on publicly available information

Sussi Bagge Mortensen

Institute of Clinical Research, University of Southern Denmark, J.B. Winsløwsvej 19, 5000 Odense C, Denmark

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Cellular Signalling
Verified
Journal Article
Closed access
GTGunnhildur Ásta Traustadóttir
Gunnhildur Ásta Traustadóttir
CJCharlotte Harken Jensen
Charlotte Harken Jensen
MTMads Thomassen
Mads Thomassen
HBHans Christian Beck
Hans Christian Beck
SMSussi B. Mortensen
Sussi B. Mortensen
DADitte Caroline Andersen
Ditte Caroline Andersen

16 October 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
SMSussi B. Mortensen
Sussi B. Mortensen
CJCharlotte Harken Jensen
Charlotte Harken Jensen
MSMikael Schneider
Mikael Schneider
MTMads Thomassen
Mads Thomassen
TKTorben A. Kruse
Torben A. Kruse
DADitte Caroline Andersen
Ditte Caroline Andersen
Adipocyte renewal from preadipocytes has been shown to occur throughout life and to contribute to obesity, yet very little is known about the molecular circuits that control preadipocyte expansion. The soluble form of the preadipocyte factor (also known as pref-1) delta-like 1 homolog (DLK1S) is known to inhibit adipogenic differentiation; however, the impact of DLK1 isoforms on preadipocyte proliferation remains to be determined. We generated preadipocytes with different levels of DLK1 and examined differentially affected gene pathways, which were functionally tested in vitro and confirmed in vivo. Here, we demonstrate for the first time that only membrane-bound DLK1 (DLK1M) exhibits a substantial repression effect on preadipocyte proliferation. Thus, by independently manipulating DLK1 isoform levels, we established that DLK1M inhibits G1-to-S-phase cell cycle progression and thereby strongly inhibits preadipocyte proliferation in vitro. Adult DLK1-null mice exhibit higher fat amounts than wild-type controls, and our in vivo analysis demonstrates that this may be explained by a marked increase in preadipocyte replication. Together, these data imply a major dual inhibitory function of DLK1 on adipogenesis, which places DLK1 as a master regulator of preadipocyte homeostasis, suggesting that DLK1 manipulation may open new avenues in obesity treatment.

28 April 2021 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
SMSussi B. Mortensen
Sussi B. Mortensen
AHAnn‐Brit E. Hansen
Ann‐Brit E. Hansen
TMTrine Mogensen
Trine Mogensen
MJMarianne A. Jakobsen
Marianne A. Jakobsen
HBHans C. Beck
Hans C. Beck
DADitte Caroline Andersen
Ditte Caroline Andersen

Verified
Journal Article
Open access
PDF file
AAAlexander Høgsted Ahlmann
Alexander Høgsted Ahlmann
SFShu Fang
Shu Fang
SMSussi Bagge Mortensen
Sussi Bagge Mortensen
LALine Weis Andersen
Line Weis Andersen
PPPernille Gejl Pedersen
Pernille Gejl Pedersen
DADitte Caroline Andersen
Ditte Caroline Andersen
Small diameter (<6 mm) vessel grafts still pose a challenge for scientists worldwide. Decellularised umbilical artery (dUA) remains promising as small diameter tissue engineered vascular graft (TEVG), yet their immunogenicity remains unknown. Herein, we evaluated the host immune responses, with a focus on the innate part, towards human dUA implantation in mice, and confirmed our findings in an ex vivo allogeneic human setup. Overall, we did not observe any differences in the number of circulating white blood cells nor the number of monocytes among three groups of mice (1) dUA patch; (2) Sham; and (3) Mock throughout the study (day −7 to 28). Likewise, we found no difference in systemic inflammatory and anti-inflammatory cytokine levels between groups. However, a massive local remodelling response with M2 macrophages were observed in the dUA at day 28, whereas M1 macrophages were less frequent. Moreover, human monocytes from allogeneic individuals were differentiated into macrophages and exposed to lyophilised dUA to maximize an eventual M1 response. Yet, dUA did not elicit any immediate M1 response as determined by the absence of CCR7 and CXCL10. Together this suggests that human dUA elicits a minimal pro-inflammatory response further supporting its use as a TEVG in an allogeneic setup.

25 May 2016 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
PDF file
KAKristian Assing
Kristian Assing
CNChristian Nielsen
Christian Nielsen
MJMarianne Jakobsen
Marianne Jakobsen
ASAlexandra Scholze
Alexandra Scholze
MNMads Nybo
Mads Nybo
CBClaus Bistrup
Claus Bistrup
Introduction: End‐stage renal disease (ESRD) is associated with increased infectious susceptibility and with reduced vaccine responses consistent with compromised humoral immunity. Whether the compromised humoral immunity is due to reduced antibody diversity (reduced somatic hypermutation [SHM]) or altered germinal center (GC) dynamics is not known. The GC‐derived chemokine CXCL13 as well as peripheral T follicular helper cells (pTFH) reflect GC dynamics, but have, similar to SHM, never been characterized in relation to ESRD.Methods: Serum CXCL 13 was determined by ELISA. PTFH were flow‐cytometrically defined as CD4+ CD45RA− CCR7+ CXCR5+ lymphocytes. Apoptotic lymphocyte subsets were in addition annexin V+. SHM was determined, by next‐generation sequencing and bioinformatics, as nucleotide mutations within the IgG VH (comprising the important antigen‐binding domains of IgG, CDR1, and CDR2).Results: Elevated CXCL13 levels characterized ESRD (n = 19; [median] 90 pg/ml, P < 0.01) (controls, n = 18; 62 pg/ml). ESRD pTFH frequencies (n = 19; 11.6% [of CD4+ memory T cells], P < 0.02*, *Bonferroni corrected) (controls, n = 22; 14.9%) and concentrations (n = 19; 0.03 × 109/L, P < 0.02*) (controls, n = 22; 0.07 × 109/L) were reduced. ESRD pTFH were more apoptotic (n = 9; 25.7%, P = 0.04*) (controls, n = 10; 15.9%). SHM did not discriminate between ESRD (n = 10; 7.4%, P = 0.21) and controls (n = 10; 8.4%).Conclusions: Elevated CXCL13 levels, reduced pTFH levels, and increased pTFH apoptosis suggest that perturbed GC dynamics, and not reduced antibody diversity, underlie the diminished vaccine responses and the compromised humoral immunity in ESRD. However, largely preserved SHM provides a rationale for pursuing vaccination in relation to ESRD.

1 July 2020 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
SMSb Mortensen
Sb Mortensen
AHAe Hansen
Ae Hansen
JLJ Lundgren
J Lundgren
TBTs Barfod
Ts Barfod
LAL Ambye
L Ambye
IJIsik Somuncu Johansen
Isik Somuncu Johansen
To investigate epidemiology, demography, and genetic and clinical characteristics of patients with familial Mediterranean fever (FMF) in Denmark. In this population-based, cross-sectional cohort st...